Protecting Digital Spaces in a Bot-Driven World 
Practice AI™ Debuts AI Suite to Boost Client Intake and Speed Case Management for Personal Injury Firms Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
HOLLISTON, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced…
Telescope Announces Stock Option Grants
Vancouver, British Columbia–(Newsfile Corp. – August 3, 2023) – Telescope Innovations Corp. (“Telescope” or the…
GA-ASI Mojave STOL UAS Completes First Dirt Operation
SAN DIEGO, CA, Aug 4, 2023 – (ACN Newswire) – On Aug. 1, 2023, General…
Armor Acquires Quantum Security, Further Strengthening Its Position in the Cloud Security and IT Risk Market
DALLAS, TX, Aug 4, 2023 – (ACN Newswire) – Armor, a leading cybersecurity company providing…
Kolibri Global Energy Announces Net Income of $4.3 Million and EPS of $0.12 Per Share for Second Quarter of 2023
THOUSAND OAKS, Calif.–(BUSINESS WIRE)–All amounts are in U.S. Dollars unless otherwise indicated: SECOND QUARTER HIGHLIGHTS…
EOS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eos Energy Enterprises and Encourages Investors to Contact the Firm
NEW YORK–(BUSINESS WIRE)–#Action–Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces…
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage…
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of Directors
SAN FRANCISCO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage…
Terns Pharmaceuticals Announces Leadership Transition
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons FOSTER CITY, Calif., Aug….
Terns Pharmaceuticals Announces Leadership Transition
Senthil Sundaram Stepping Down as Chief Executive Officer for Health Reasons FOSTER CITY, Calif., Aug….
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Cellectis Provides Business Updates and Preliminary Financial Results for Second Quarter 2023
Updated clinical & translational data on BALLI-01 trial (evaluating UCART22 in r/r B-cell ALL) presented at…
Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…